Central drug regulator preparing list of dual-use APIs imported from unregistered firms

Dual-use APIs, which are being imported from unregistered companies, are comparatively cheaper and of low-quality.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Za6S5g
via IFTTT